Literature DB >> 11395135

Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus.

I F Dunn1, T Y Sannikova, R S Geha, E N Tsitsikov.   

Abstract

We have shown that CD40 engagement induces TRAF1 gene expression in B lymphocytes. Here we report that CD40-dependent TRAF1 gene transcription in murine B cells is controlled by two enhancer regions. One region is located approximately 2 kb upstream of the transcription start site and the other lies in the intron between exons 5 and 6. The upstream enhancer contains a single NF-kappaB site in addition to sites that bind constitutive transcription factors. Mutation of this NF-kappaB site completely abrogates CD40-driven TRAFl transcription. The intronic enhancer contains two sites that strongly bind the CD40-inducible factors NF-kappaB and AP-1. Simultaneous mutation of the AP-1 site and of the NF-kappaB site abolishes transcription driven by this enhancer. When cloned together into reporter constructs, the two TRAF1 enhancers do not synergize, suggesting that each enhancer may separately participate in the induction of TRAF1 transcription in B cells following CD40 activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11395135     DOI: 10.1016/s0161-5890(01)00015-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.

Authors:  Anna Missiou; Natascha Köstlin; Nerea Varo; Philipp Rudolf; Peter Aichele; Sandra Ernst; Christian Münkel; Carina Walter; Peter Stachon; Benjamin Sommer; Dietmar Pfeifer; Katja Zirlik; Lindsey MacFarlane; Dennis Wolf; Erdyni Tsitsikov; Christoph Bode; Peter Libby; Andreas Zirlik
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

2.  CD40/TRAF1 decreases synovial cell apoptosis in patients with rheumatoid arthritis through JNK/NF-κB pathway.

Authors:  Tao Cheng; Jian Wu; Yaozeng Xu; Cuiping Liu; Huayong Zhang; Mingjun Wang
Journal:  J Bone Miner Metab       Date:  2022-08-12       Impact factor: 2.976

3.  Traf1 induction and protection from tumor necrosis factor by nuclear factor-kappaB p65 is independent of serine 536 phosphorylation.

Authors:  Carl Y Sasaki; Colin F Slemenda; Paritosh Ghosh; Theresa J Barberi; Dan L Longo
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 4.  Recent advances in the genetics of autoimmune disease.

Authors:  Peter K Gregersen; Lina M Olsson
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling.

Authors:  Joseph R Arron; Yael Pewzner-Jung; Matthew C Walsh; Takashi Kobayashi; Yongwon Choi
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

6.  TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.

Authors:  X-F Zhang; R Zhang; L Huang; P-X Wang; Y Zhang; D-S Jiang; L-H Zhu; S Tian; X-D Zhang; H Li
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

7.  Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.

Authors:  Carl Philipp Simon-Gabriel; Katharina Foerster; Shifa Saleem; Dorothee Bleckmann; Marco Benkisser-Petersen; Nicolas Thornton; Kazuo Umezawa; Sarah Decker; Meike Burger; Hendrik Veelken; Rainer Claus; Christine Dierks; Justus Duyster; Katja Zirlik
Journal:  Haematologica       Date:  2017-11-09       Impact factor: 9.941

Review 8.  CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs.

Authors:  Juan M Zapata; Gema Perez-Chacon; Pablo Carr-Baena; Ivan Martinez-Forero; Arantza Azpilikueta; Itziar Otano; Ignacio Melero
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

Review 9.  The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis.

Authors:  Mark Colin Gissler; Peter Stachon; Dennis Wolf; Timoteo Marchini
Journal:  Front Cardiovasc Med       Date:  2022-02-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.